/
/
/

Epigral Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)989.90
Volume (₹)24,671.00
High (₹)1,008.90
Upper Circuit1,189.00
Low (₹)980.50
Lower Circuit792.80
Prev Close990.90
52W High (₹)1,729.90
Price1,000.00
52W Low (₹)807.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)4268.62 Cr
Div. Yield (%)0.51
PE Ratio15.75
Debt to Equity0.25
Price to Book1.57
Book Value514.94
EPS (TTM)62.82
Face Value10.00
ROE (%)16.09

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
NAVINFLUORNSE
GODREJINDNSE
AETHERNSE
DEEPAKNTRNSE
AARTIINDNSE
ATULNSE
EPIGRALNSE
LTP
1W Low
1W High
Market cap (₹)
20170+170 (0.85%)
19925
20398
1,81,930Cr
1499.5+17.5 (1.18%)
1462
1506.20
1,52,271Cr
2499.7-19.8 (-0.79%)
2452.50
2535.80
73,810Cr
4632.1+155.3 (3.47%)
4485
4680
49,998Cr
8457+104.5 (1.25%)
8330.50
8605
43,440Cr
1004+18.6 (1.89%)
980.40
1012.90
33,630Cr
1682.5-65.6 (-3.75%)
1659.10
1810
22,785Cr
1645.4+23.5 (1.45%)
1597.20
1662.50
22,109Cr
497.9+37.75 (8.20%)
460.45
499.90
17,680Cr
5972+89.5 (1.52%)
5891
6074.50
17,655Cr
1000+3.6 (0.36%)
966
1014.80
4,269Cr

Key Highlights of Epigral Ltd Balance Sheet

Epigral Ltd balance sheet discloses shareholders' funds of ₹43.14Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹43.14Cr, and the reserves and surplus of the company is ₹2178.33Cr.

The company has its non-current liabilities with total liabilities of ₹3505.34Cr as of 2026-03-31.

The current liabilities are ₹710.42Cr as of 2026-03-31. At the same time, current assets are ₹826.69Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹22.8Cr and tangible assets of ₹2117.19Cr, provided in the Epigral Ltd financial statements.